Patent · US Active

CMYBP-C and MLC2 as diagnostic markers of cardiac injury

US8546089B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignee

KING'S COLLEGE LONDON · GB

Inventors

Manuel Mayr · Walldorf, DE
Sebastien Jacquet · Saint-Jean-d'Arvey, FR
Michael Marber · London, GB
Mathias Gautel · London, GB

Key dates

Filing date	May 11, 2010
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Jun 29, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/324
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to markers for acute myocardial infarction (AMI), particularly markers that may be used in the rapid and accurate diagnosis of AMI or reinfarction. A method of diagnosing cardiac injury comprising identifying an elevated concentration of cardiac myosin binding protein C (cMyBP-C) or a fragment thereof or myosin regulatory light chain 2 (MLC2) or a fragment thereof in a sample obtained from a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.